GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Interest Expense

Shanghai Kehua Bio-engineering Co (SZSE:002022) Interest Expense : ¥-45 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Kehua Bio-engineering Co's interest expense for the three months ended in Mar. 2024 was ¥ -12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-45 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Kehua Bio-engineering Co's Operating Income for the three months ended in Mar. 2024 was ¥ -24 Mil. Shanghai Kehua Bio-engineering Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -12 Mil. Shanghai Kehua Bio-engineering Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Kehua Bio-engineering Co Interest Expense Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Interest Expense Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.95 -34.95 -40.15 -40.06 -43.74

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.25 -10.94 -11.18 -11.37 -11.83

Shanghai Kehua Bio-engineering Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kehua Bio-engineering Co  (SZSE:002022) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Kehua Bio-engineering Co's Interest Expense for the three months ended in Mar. 2024 was ¥-12 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥-24 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥801 Mil.

Shanghai Kehua Bio-engineering Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Shanghai Kehua Bio-engineering Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Interest Expense
Comparable Companies
SZSE:300314 SZSE:300326 SHSE:688358 SHSE:688580 SHSE:688317 SZSE:301033 SHSE:605186 SHSE:688085 SHSE:688338 SZSE:002932 ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Website
http://www.skhb.com
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines